Background-We prospectively evaluated the incremental prognostic value of transient ischemic dilation (TID) in patients with type 2 diabetes mellitus during long-term follow-up and estimated cardiac death and nonfatal myocardial infarction (MI) using traditional approaches of prognostication to more recent methods. Methods and Results-A total of 672 consecutive diabetic patients with available rest and stress gated myocardial perfusion single-photon emission computed tomographic data were enrolled. Stepwise Cox regression analysis was used to estimate cardiac death or nonfatal MI. Risk reclassification was calculated, and an exploratory analysis was performed to evaluate the effect of coronary revascularization on event-free survival. Adding TID to a multivariable model, including age, history of MI, stress type, poststress left ventricular ejection fraction, and stress-induced myocardial ischemia, improved discrimination of cardiac death or nonfatal MI (C statistic, 0.74-0.82; P=0.01; adjusted hazard ratio, 3.6; P<0.0001) and led to a net reclassification improvement of 0.39 (95% confidence interval, 0.14-0.64). Revascularization had a significant effect on event-free survival (adjusted hazard ratio, 0.25; P<0.001), with significant interactions between revascularization and poststress left ventricular ejection fraction, revascularization and stress-induced myocardial ischemia, and revascularization and TID (all P<0.01) Conclusions-TID provides independent and incremental prognostic information for the prediction of cardiac death or nonfatal MI in patients with diabetes mellitus. The addition of TID to a prediction model based on cardiovascular risk factors, left ventricular ejection fraction, and ischemia significantly improves risk discrimination and reclassification for incident cardiac events. The effect of revascularization seems to be influenced by left ventricular systolic function, stressinduced myocardial ischemia, and TID. (Circ Cardiovasc Imaging. 2013;6:908-915.)
P atients with type 2 diabetes mellitus are at increased risk for cardiovascular disease and mortality. [1] [2] [3] Beyond traditional cardiovascular risk factors, other measures reflecting additional aspects of disease pathophysiology may be useful for risk stratification. Stress gated myocardial perfusion single-photon emission computed tomography (MPS) is widely used for the diagnosis of coronary artery disease (CAD) and for risk stratification. 4 Transient ischemic dilation (TID) of the left ventricle during stress MPS has been associated with severe and extensive CAD and adverse outcome. [5] [6] [7] [8] [9] [10] The presence of diabetes mellitus might modify the relationship between TID and the angiographic severity of CAD. 11, 12 In addition, diabetes mellitus and its long-term unsatisfactory compensation might affect TID of the left
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ventricle. 13 These findings raise important questions about the pathophysiology and the diagnostic and prognostic value of TID in the presence of diabetes mellitus. Recently, Petretta et al 14 found that TID provides incremental diagnostic information over standard myocardial perfusion analysis for the identification of severe and extensive CAD in patients with diabetes mellitus. However, investigations on the prognostic value of TID in large cohorts of patients with diabetes mellitus are still lacking. Therefore, we prospectively evaluated the incremental prognostic value of TID in patients with type 2 diabetes mellitus during long-term follow-up and estimated cardiac death or nonfatal myocardial infarction (MI) using traditional approaches of prognostication to more recent methods. We also performed an exploratory analysis to assess the relationship between clinical outcome and coronary revascularization procedures according to gated MPS findings.
Methods

Study Population
The study population included 692 consecutive patients with type 2 diabetes mellitus and available rest and stress gated MPS data, referred for MPS for the detection of myocardial ischemia. As part of the baseline examination, we collected information on cardiovascular risk factors, presenting symptoms, and history of CAD. Patients were excluded for (1) recurrent chest pain unresponsive to anti-ischemic medications; (2) recent acute coronary syndrome, stroke, or transient ischemic attack (past 3 months); (3) uncompensated congestive heart failure or recent admission for congestive heart failure; (4) prior myocardial revascularization procedures; (5) an absolute contraindication to dipyridamole in patients unable to exercise; or (6) a concomitant noncardiac illness that would limit follow-up for ≥1 year. The review committee of our institution approved the study, and all patients gave informed consent.
Gated MPS
All patients underwent same-day Tc-99m sestamibi rest and stress gated MPS by exercise or dipyridamole stress test according to the recommendations of the European Association of Nuclear Medicine and European Society of Cardiology, 15 as previously described in detail. 16 An automated software program was used to calculate left ventricular (LV) volumes and ejection fraction (EF) and the scores incorporating both the extent and severity of perfusion defects 17 using standardized segmentation of 17 myocardial regions. An LVEF ≤45% was considered abnormal. For each patient, the ratio of stress mean LV volumes to rest mean LV volumes was calculated, and a cutoff value of ≥1.19 was considered to represent TID for both exercise and dipyridamole stress test. 8, 14 Each myocardial segment was scored from normal (score=0) to absent perfusion (score=4). The summed stress score was obtained by adding the scores of the 17 segments of the stress images. A similar procedure was applied to the resting images to calculate the summed rest score. The summed difference score represents the difference between the stress and rest scores and is taken to be an index of ischemic burden. Patients were considered to have no ischemia with a summed difference score of 0 to 1, mild ischemia with a summed difference score of 2 to 6, and moderatesevere ischemia with a summed difference score >6.
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Follow-up Data
Patient follow-up was prospectively obtained by use of a questionnaire that was assessed by a phone call to all patients and general practitioners or cardiologists and by review of hospital or physicians' records by individuals blinded to the patient's test results. The end point was the occurrence of cardiac death or nonfatal MI, whichever occurred first. Cardiac death, because of acute MI, ventricular arrhythmias, refractory heart failure, or cardiogenic shock, was confirmed by review of death certificate, hospital chart, or physician's records. Nonfatal MI was defined based on the criteria of typical chest pain, elevated cardiac enzyme levels, and typical alterations in the ECG. Patients experiencing noncardiac death during follow-up were censored at the time of death. Revascularization procedures during follow-up and time to first revascularization from the index MPS study were also noted. The decision to submit a patient to revascularization was made by referring physician, taking into account all available information and patient preferences. The date of the last examination or consultation was used to determine the length of follow-up. 10 for model retention) was performed with the above-described covariates. Variables significant at stepwise analysis (age, history of MI, stress type, poststress LVEF ≤45%, and moderate-severe ischemia) constituted model 1. To address the incremental prognostic value of TID, we added TID to the variables included in model 1 to obtain an adjusted hazard ratio for TID (model 2). In addition, we assessed for significant incremental changes in model C statistic before and after addition of TID. 19 For multivariable models, the proportional hazard assumption was validated by visual inspection of the log[−log(survivor function)] for categorical variables and with statistical tests based on Schoenfeld residuals for continuous variables. Collinearity was checked using the variance inflation factor. 20 To assess the ability of TID to reclassify patients, we performed net reclassification improvement (NRI) analysis using the category-free NRI proposed by Pencina et al. 21 Pretest risk was defined by the probability of cardiac death or nonfatal MI estimated at Cox analysis by the variables (age, history of MI, stress type, poststress LVEF ≤45%, and moderate-severe ischemia) included in model 1. Post-test risk was defined by the probability of cardiac death or nonfatal MI estimated at Cox analysis by these variables plus TID (model 2).
Statistical Analysis
An exploratory analysis was performed to evaluate the possible relationship between clinical outcome and coronary revascularization according to gated MPS findings. For this purpose, a multivariable Cox regression model was constructed considering as covariates coronary revascularization (time-dependent covariate), poststress LVEF, MPS ischemia, and TID. We also assessed 3 interactions: revascularization and LVEF, revascularization and MPS ischemia, and revascularization and TID.
All statistical analyses were performed with Stata 12.1 software (StataCorp, College Station, TX). A 2-tailed P<0.05 was considered statistically significant.
Results
Patient Characteristics and Outcome
The study cohort comprised 692 patients. Follow-up data were not available for 20 patients (2.9%), with a mean age of 64±8 years and a prevalence of cardiovascular risk factors, presenting symptoms, and history of CAD comparable with the 672 patients with available follow-up data. In these latter patients, the duration of diabetes mellitus was 120±113 months, and the number of cardiovascular risk factors besides diabetes mellitus was 2.1±1.1. Patients with history of MI compared with those without had higher prevalence of poststress LVEF ≤45% (38% versus 15%; P<0.001) and MPS ischemia (63% versus 38%; P<0.001), whereas the prevalence of TID was comparable (13% versus 15%; P=0.41). The median followup for surviving patients was 47.8 months (interquartile range, 41.6-59.1 months).
During follow-up, 63 end point events occurred (9.4% cumulative event rate). The events were cardiac death in 39 patients and nonfatal MI in 24 patients. Five patients died of noncardiac death. The median follow-up was 2.2 years for the 63 patients with events and 3.9 years for the 609 patients without events. The median follow-up was 2.4 years for the 24 live patients who experienced MI and 4.0 years for the 604 live patients not experiencing MI. The median follow-up was 1.9 years for the 39 patients died of cardiac death and 2.1 years for the 5 patients of noncardiac death. The characteristics of patients with and without events are given in Table 1 . The majority of patients with events underwent pharmacological stress test (P=0.006). Rest LVEF ≤45% was present in 27 (43%) patients who experienced events and in 107 (18%) of those without events (P<0.001). Poststress LVEF ≤45% was present in 30 (48%) patients with events and in 129 (21%) patients without events (P<0.001). MPS ischemia was present in 44 (70%) patients with events (mild in 26 and moderatesevere in 18) and in 303 (50%) patients without events (mild in 215 and moderate-severe in 88; P=0.002). TID was detectable in 35% of patients with events and in 12% of those without events (P<0.001).
Predictors of Cardiac Death and Nonfatal MI
Univariable associations of age, sex, traditional cardiovascular risk factors, and stress MPS indices with cardiac death or nonfatal MI were measured ( Table 2 ). As shown, TID was a strong predictor of cardiac events. The Kaplan-Meier analysis showed that the overall event-free survival was lower in patients with TID than in those without (χ 2 , 25.2; P<0.001; Figure 1A ). Noteworthy, when only patients with otherwise normal gated MPS (poststress LVEF >45% and no ischemia) were considered, TID predicted cardiac events at long-term follow-up (χ 2 , 31.6; P<0.001; Figure 1B ). The results of multivariable survival analysis for prediction of cardiac death or nonfatal MI including as potential covariates patient age, sex, body mass index, dyslipidemia, smoking, hypertension, family history of CAD, chest pain symptoms, history of MI, stress type, poststress LVEF ≤45%, and moderate-severe ischemia are reported in Table 3 .
Improvement of Risk Discrimination and NRI
Results of stepwise Cox regression analysis are reported in Table 4 . Model 1 consisted of variables significant at stepwise analysis (age, history of MI, dipyridamole stress test, poststress LVEF, and moderate-severe ischemia). When TID was added to model 1, it improved the model discrimination (C statistic increased from 0.74 of model 1 to 0.82 of model 2; P=0.01; adjusted hazard ratio, 3.6; P<0.0001) and goodness of fit (global χ 2 =63.7 for model 1 and 78.9 for model 2; P=0.001). The variance inflation factor was <2 for all variables in the models, and the correlation among poststress LVEF, moderate-severe ischemia, and TID was <0.4, suggesting the lack of significant collinearity. The addition of TID to model 1 led to an NRI of 0.39 (95% confidence interval, 0.14-0.64).
Subgroup Analysis
The effect of TID on cardiac death or nonfatal MI was evaluated separately in 3 subgroups of patients: group 1, poststress LVEF >45% without MPS ischemia (n=253); group 2, poststress LVEF >45% with MPS ischemia (n=260); and group 3, poststress LVEF ≤45% with MPS ischemia (n=138). The effect of TID on annualized crude event rates was consistent across the subgroups evaluated (Figure 2) , suggesting a potential effect of this measure in clinical practice.
Effect of Revascularization on Outcome
During follow-up, 147 patients underwent coronary revascularization procedures (43 coronary artery bypass grafting and 104 percutaneous coronary intervention, 2 without and 102 with stent implantation). The median time from the index MPS to revascularization was 9.8 months (range 3.8-21.7 months). The characteristics of patients undergoing revascularization are given in Table 5 . MPS ischemia was present in 113 (77%) patients with revascularization (mild in 62 and moderatesevere in 51) and in 208 (40%) patients without revascularization (mild in 153 and moderate-severe in 55; P<0.001). At multivariable Cox analysis, performed considering coronary revascularization and gated MPS variables, revascularization had a significant effect on cardiac events (adjusted hazard ratio, 0.25; 95% confidence interval, 0.11-0.38; P<0.001). Also, the 3 interaction terms between revascularization and poststress LVEF, revascularization and MPS ischemia, and revascularization and TID were significant (all P<0.01), indicating effect modification by revascularization on the association between these indices and cardiac events.
Discussion
To the best of our knowledge, this is the first study addressing the incremental prognostic value of TID in patients with type 2 diabetes mellitus. Our results reveal that the addition of TID to clinical data, poststress LVEF, and myocardial ischemia is important for estimating the risk of cardiac death or nonfatal MI and is effective in reclassifying patients beyond traditional approaches of prognostication.
Prognostic Value of TID
Beyond its use in identifying severe and extensive CAD, [5] [6] [7] [8] 14 several studies demonstrated that TID also provides important prognostic information. In particular, McClellan et al 22 reported on 512 consecutive patients (25% with diabetes mellitus) who underwent dipyridamole stress MPS. During a follow-up period of 13±7 months, cardiac event rates, including cardiac death and nonfatal MI, were significantly higher in patients with TID (11%) and in those with fixed dilation (14%) than in those with normal LV size (2%). In another study, Krawczynska et al 23 found that LV dilation on Tl-201 MPS was an independent predictor of death in patients with large perfusion defects. However, this study did not differentiate fixed from transient LV dilation and fixed from reversible perfusion defects.
Although the prognostic use of TID has been demonstrated, its independent and incremental value has been less explored. Murthy et al, 24 in a large population of 1883 consecutive patients (36% with diabetes mellitus) referred for rest-stress positron emission tomography followed up for a median of 1.4 years, found that incorporation of TID into a model containing clinical risk factors, LVEF, extent of ischemia and scar, and stress-induced LVEF augmentation was not associated with an improved model fit, increased C index, or positive NRI. Similarly, more recent data obtained in 203 patients with suspected or known CAD (approximately one third with diabetes mellitus) who underwent rest-dipyridamole 82-Rb positron emission tomography suggest that although TIDpositive subjects had a lower overall survival probability, the only independent significant predictor of events was an LVEF <45%. 25 In the present investigation, we focused our attention on patients with diabetes mellitus, which represent a population at high risk of cardiac events. We found that the addition of TID to clinical data, poststress LVEF, and myocardial ischemia was important for estimating the risk of cardiac events and was effective in reclassifying patients beyond traditional approaches of prognostication. In particular, the addition of TID to the comprehensive model based on clinical data, poststress LVEF, and myocardial ischemia improved model fit (P=0.001) and the C index (P=0.01) and was associated with favorable risk reclassification (NRI=0.39). Although the association between TID and both ischemia and severe CAD has been well documented, TID is more frequent in patients with diabetes mellitus, suggesting that the pathophysiology of this disease process plays an integral role in the manifestation of TID on stress MPS. 12 Diabetes mellitus can cause coronary flow reserve abnormalities also in the absence of significant epicardial coronary stenoses. [26] [27] [28] Endothelium-dependent (response to cold pressor testing) and endothelium-independent coronary vasodilator function is impaired in patients with diabetes mellitus, with no known CAD. 29 Therefore, the contribution of diabetes mellitus to TID and the implications of TID in patients with diabetes mellitus must be considered.
Patients with Otherwise Normal MPS
The role of TID in patients with otherwise normal MPS is still controversial. Abidov et al 9 showed that in these patients TID is an independent and incremental prognostic marker of cardiac events even after significant clinical variables were taken into account. Other studies suggested that even in the absence of perfusion abnormalities, stress-induced LV dilation is an independent marker of increased risk. 23, 30 Differently, Valdiviezo et al 31 reported that in patients with an otherwise normal MPS, TID does not increase the likelihood of CAD, its extent, or severity and is not associated with worsened patient survival. Although TID is described as an indicator of severe CAD, which correlates with the degree of ischemia, van der Veen et al 32 found no correlation between TID and degree of ischemia in patients undergoing pharmacological stress testing and suggested that TID should be used as a complementary parameter, in combination with other perfusion, motion, and thickening measurements, and never as a single indicator of extensive CAD. More recent data, obtained in a subgroup of patients with normal regional perfusion, showed that TID identifies patients with higher mortality and is an independent predictor of death, together with a decreased LVEF. 24 In our series of patients with diabetes mellitus, when only subjects with poststress LVEF >45% and no ischemia were considered, TID was a strong predictor of cardiac events at long-term follow-up, with an event rate of 0.21% per year in those without TID and 4.9% per year in those with TID.
Clinical Outcome After Coronary Revascularization
In patients with type 2 diabetes mellitus, the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial reported no difference in the primary outcome of event-free survival between patients assigned to a strategy of medical therapy compared with prompt coronary revascularization. 33 A subsequent analysis of the BARI 2D trial found that a strategy of prompt coronary artery bypass graft surgery significantly reduced the rate of death, MI, and stroke in patients with extensive CAD or impaired LV function. 34 In addition, Shaw et al 35 examined the prognostic use and differential therapeutic risk reduction by the extent and the severity of stress MPS abnormalities and poststress LVEF at 1 year after randomization. They found that revascularization was associated with reductions in myocardial ischemia compared with medical therapy and that a 1-year post-therapeutic intervention gated MPS provided important information on prognosis. 35 In the present study, we explored the possible relationship between clinical outcome and coronary revascularization procedures according to gated MPS findings. In our study population, stress-induced ischemia was more frequent among patients undergoing revascularization and at multivariable Cox analysis revascularization had a significant effect on cardiac events. Our observational analysis also suggests that the effect of coronary revascularization is influenced by LV systolic function, MPS ischemia, and TID.
Study Limitations
The present study is a cohort study and carries all of the inherent limitations of that study design. In addition, we were not able to evaluate the downstream effect of TID on patient management decisions because referring clinicians were not informed of TID results in clinical reports. This reduces bias in estimates of TID effect size introduced by subsequent treatment decisions based on this result. However, the lack of randomization to evaluate the effect of revascularization on outcome represents a major limitation, and no treatment benefit may be inferred by our exploratory analysis. In addition, 20 patients were lost at follow-up; however, their clinical characteristics were comparable with those of the 672 patients with available follow-up data. Finally, the subgroup analyses are limited by the relatively small sample size.
Conclusions
The results of this study indicate that TID provides independent and incremental prognostic information for the prediction of cardiac death or nonfatal MI in patients with type 2 diabetes mellitus. The addition of TID to a prediction model based on clinical data, poststress LVEF, and myocardial ischemia improves risk discrimination and reclassification for incident cardiac events. Furthermore, the effect of revascularization seems to be influenced by LV systolic function, MPS ischemia, and TID.
